Editorial: Recompensation in PBC is good. But is it good enough?
- PMID: 38591801
- DOI: 10.1111/apt.17924
Editorial: Recompensation in PBC is good. But is it good enough?
Comment in
-
Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.Aliment Pharmacol Ther. 2024 May;59(9):1146-1147. doi: 10.1111/apt.17966. Aliment Pharmacol Ther. 2024. PMID: 38591799 No abstract available.
Comment on
-
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.Aliment Pharmacol Ther. 2024 Apr;59(8):962-972. doi: 10.1111/apt.17908. Epub 2024 Feb 26. Aliment Pharmacol Ther. 2024. PMID: 38409879
References
REFERENCES
-
- De Veer R, van Hooff MC, Corpechot C, et al. Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. Aliment Pharmacol Ther. 2022;56(9):1408–1418.
-
- Gatselis N, Goet J, Zachou K, Lammers WJ, Janssen HLA, Hirschfield G, et al. Factors associated with progression and outcomes of early stage primary biliary cholangitis. Clin Gastroenterol Hepatol. 2020;18(3):684–692.
-
- Harms MH, Lammers WJ, Thorburn D, Corpechot C, Invernizzi P, Janssen HLA, et al. Major hepatic complications in ursodeoxycholic acid‐treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome. Am J Gastroenterol. 2018;113:254–264.
-
- European Association for the Study of the Liver. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145–172.
-
- Hofer BS, Simbrunner B, Burghart L, Halilbasic E, Petrenko O, Mandorfer M, et al. Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Aliment Pharmacol Ther. 2024;59:962–972.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources